Uterocervical Angle in the Termination of Second Trimester Pregnancy

NCT03220607 | Completed

• 1 other identifier: 2016/5
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the performance of uterocervical angle (UCA) in the prediction of second trimester terminations.

Conditions

Abortion, Second Trimester

Keywords

uterocervical angle, second trimester abortion

Outcome Measures

Primary Outcomes (1)

• uterocervical angle

  the angle between the lower segment of uterus and cervix

  once at the beginning of enrollment

Study Arms (1)

Medical induced abortion

120 singleton nulliparous patients are planning to complete the study period. Study group constitute of second trimester pregnancies between 14-24 weeks of gestation. All participants were nulliparous and had no systemic illnesses. The uterocervical angle will be measured in all participants before the induction of labor.

Other: uterocervical angle

Interventions

uterocervical angle OTHER

uterocervical angle is the angle between lower segment of uterus and cervix

Medical induced abortion

Eligibility Criteria

• Age: 18 Years - 40 Years
• Gender Eligibility Details: Pregnant population undergoing second trimester abortion
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant population undergoing medical induced second trimester abortion.

You may qualify if:

• Nulliparous singleton pregnancy
• no previous systemic illnesses

You may not qualify if:

• abnormal Pap smear
• previous cesarean section
• history of dilatation and curettage (D\&C)
• history of LEEP and cervical conization

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Kanuni SSTRH

Istanbul, 34303, Turkey (Türkiye)

Location

Related Links

• Uterocervical angle: a novel ultrasound screening tool to predict spontaneous preterm birth.

Study Officials

• Alev Atis, MD,ObGyn

  Kanuni Sultan Suleyman Training and Research Hospital

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 4 Days
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD,ObGYN

Study Record Dates

• First Submitted: July 14, 2017
• First Posted: July 18, 2017
• Study Start: October 15, 2016
• Primary Completion: August 30, 2017
• Study Completion: September 1, 2017
• Last Updated: September 6, 2017

Record last verified: 2017-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)